Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 8.181
Filtrer
1.
J Ovarian Res ; 17(1): 138, 2024 Jul 04.
Article de Anglais | MEDLINE | ID: mdl-38965577

RÉSUMÉ

BACKGROUND: To investigate whether melatonin supplementation can enhance cardiometabolic risk factors, reduce oxidative stress, and improve hormonal and pregnancy-related factors in patients with PCOS. METHODS: We conducted a systematic search of PubMed/Medline, Scopus, and the Cochrane Library for articles published in English from inception to March 2023. We included randomized controlled trials (RCTs) on the use of melatonin for patients with polycystic ovary syndrome (PCOS). We performed a meta-analysis using a random-effects model and calculated the standardized mean differences (SMDs) and 95% confidence intervals (CIs). RESULTS: Six studies met the inclusion criteria. The result of meta-analysis indicated that melatonin intake significantly increase TAC levels (SMD: 0.87, 95% CI: 0.46, 1.28, I2 = 00.00%) and has no effect on FBS, insulin, HOMA-IR, TC, TG, HDL, LDL, MDA, hs-CRP, mFG, SHBG, total testosterone, and pregnancy rate in patients with PCOS compare to controls. The included trials did not report any adverse events. CONCLUSION: Melatonin is a potential antioxidant that may prevent damage from oxidative stress in patients with PCOS. However, the clear effect of melatonin supplementation on cardiometabolic risk factors, hormonal outcomes, and pregnancy-related outcomes needs to be evaluated further in large populations and long-term RCTs.


Sujet(s)
Facteurs de risque cardiométabolique , Compléments alimentaires , Mélatonine , Stress oxydatif , Syndrome des ovaires polykystiques , Essais contrôlés randomisés comme sujet , Humains , Mélatonine/pharmacologie , Mélatonine/usage thérapeutique , Syndrome des ovaires polykystiques/traitement médicamenteux , Syndrome des ovaires polykystiques/sang , Femelle , Stress oxydatif/effets des médicaments et des substances chimiques , Grossesse , Hormones/sang , Antioxydants/pharmacologie , Antioxydants/usage thérapeutique , Antioxydants/administration et posologie
2.
Noise Health ; 26(121): 186-191, 2024.
Article de Anglais | MEDLINE | ID: mdl-38904821

RÉSUMÉ

OBJECTIVE: This study aims to investigate the effects of nighttime noise management in intensive care units (ICU) on hormone levels and sleep quality in conscious patients. METHODS: From March 2020 to March 2021, the routine noise management for conscious patients was implemented in the ICU of Wenzhou TCM Hospital of Zhejiang Chinese Medical University. During this time, 86 patients were selected as the study subjects; five patients who did not meet the inclusion criteria were excluded, and 81 patients were included in the reference group. From April 2021 to April 2022, nighttime noise management for conscious patients was conducted, during which 93 patients were selected as the research subjects; six patients who did not meet the inclusion criteria were excluded, and 87 patients were included in the observation group. The hormone indicators, Pittsburgh Sleep Quality Index (PSQI) scores, and Symptom Checklist-90 (SCL-90) scores were collected and compared. RESULTS: After management, the observation group had significantly lower noise level and hormone indicators (P < 0.05), significantly lower PSQI score (P < 0.001) and significantly lower SCL-90 score than the reference group (P < 0.01). CONCLUSION: Nighttime noise in the ICU has an adverse effect on conscious patients. Nighttime noise management improves the hormone levels and sleep quality of ICU patients.


Sujet(s)
Unités de soins intensifs , Bruit , Qualité du sommeil , Humains , Mâle , Bruit/effets indésirables , Femelle , Adulte d'âge moyen , Adulte , Hormones/sang , Sujet âgé , Chine , Conscience
3.
Mol Cell Endocrinol ; 591: 112268, 2024 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-38735622

RÉSUMÉ

Menopause causes important bodily and metabolic changes, which favor the increased occurrence of cardiovascular diseases, obesity, diabetes, and osteoporosis. Resveratrol exerts proven effects on body metabolism, improving glucose and lipid homeostasis and reducing inflammation and oxidative stress in various organs and tissues. Accordingly, this study evaluates the effects of resveratrol supplementation on the expression of markers associated with thermogenesis in brown adipose tissue, and on the body, metabolic and hormonal parameters of female mice submitted to bilateral oophorectomy. Eighteen female mice were randomized into three groups: G1: control (CONTROL), G2: oophorectomy (OOF), and G3: oophorectomy + resveratrol (OOF + RSV); the animals were kept under treatment for twelve weeks, being fed a standard diet and treated with resveratrol via gavage. Body, biochemical, hormonal, and histological parameters were measured; in addition to the expression of markers associated with thermogenesis in brown adipose tissue. The results showed that animals supplemented with resveratrol showed reduced body weight and visceral adiposity, in addition to glucose, total cholesterol, and triglyceride levels; decreased serum FSH levels and increased estrogen levels were observed compared to the OOF group and mRNA expression of PRDM16, UCP1, and SIRT3 in brown adipose tissue. The findings of this study suggest the important role of resveratrol in terms of improving body, metabolic, and hormonal parameters, as well as modulating markers associated with thermogenesis in brown adipose tissue of female mice submitted to oophorectomy.


Sujet(s)
Tissu adipeux brun , Compléments alimentaires , Ovariectomie , Resvératrol , Thermogenèse , Protéine-1 de découplage , Animaux , Resvératrol/pharmacologie , Resvératrol/administration et posologie , Femelle , Thermogenèse/effets des médicaments et des substances chimiques , Thermogenèse/génétique , Souris , Tissu adipeux brun/métabolisme , Tissu adipeux brun/effets des médicaments et des substances chimiques , Protéine-1 de découplage/génétique , Protéine-1 de découplage/métabolisme , Administration par voie orale , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Facteurs de transcription/génétique , Facteurs de transcription/métabolisme , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , Sirtuine-3/génétique , Sirtuine-3/métabolisme , Poids/effets des médicaments et des substances chimiques , Hormones/sang
4.
Toxicology ; 505: 153833, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38759721

RÉSUMÉ

Electronic waste (e-waste) contains numerous metals and organic pollutants that have detrimental impacts on human health. We studied 199 e-waste recycling workers and 104 non-exposed workers; analyzed blood, urine, and hair samples to measure heavy metals, hormonal, liver, and renal function. We used quantile regression models to evaluate the impact of Pb, Cd, and Hg on hormonal, liver and renal function, and the role of DNA oxidative damage in mediating the relationship between exposures and outcomes. Exposed workers had higher blood lead (Pb) (median 11.89 vs 3.63 µg/dL), similar blood cadmium (Cd) (1.04 vs 0.99 µg/L) and lower total mercury (Hg) in hair (0.38 vs 0.57 ppm) than non-exposed group. Exposed workers also had elevated median concentrations of total triiodothyronine (TT3), aspartate aminotransferase (AST), alanine aminotransferase (ALT), urinary albumin, albumin creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) were significantly higher than non-exposed group (p≤0.05). Sex hormones including luteinizing hormone, follicle stimulating hormone, estrogen, progesterone and testosterone concentrations were not significantly different between exposed and non-exposed (all p≥0.05). The median concentration of ALT was 4.00 (95% CI: 0.23, 7.77), urinary albumin was 0.09 (95% CI: 0.06, 0.12) and ACR was 1.31 (95% CI: 0.57, 2.05) units higher in the exposed group compared to non-exposed group. Pb was associated with a 3.67 unit increase in the ALP (95% CI: 1.53, 5.80), 0.01 unit increase in urinary albumin (95% CI: 0.002, 0.01), and 0.07 unit increase in ACR (95% CI: 0.01, 0.13). However, no hormonal, renal, and hepatic parameters were associated with Cd or Hg. Oxidative DNA damage did not mediate exposure-outcome relationships (p≥0.05). Our data indicate e-waste exposure impairs liver and renal functions secondary to elevated Pb levels. Continuous monitoring, longitudinal studies to evaluate the dose-response relationship and effective control measure are required to protect workers from e-waste exposure.


Sujet(s)
Déchets électroniques , Rein , Exposition professionnelle , Humains , Déchets électroniques/effets indésirables , Adulte , Mâle , Exposition professionnelle/effets indésirables , Exposition professionnelle/analyse , Femelle , Bangladesh/épidémiologie , Rein/effets des médicaments et des substances chimiques , Rein/métabolisme , Rein/physiopathologie , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Adulte d'âge moyen , Métaux lourds/urine , Métaux lourds/sang , Métaux lourds/toxicité , Recyclage , Jeune adulte , Cadmium/sang , Cadmium/urine , Cadmium/toxicité , Poils/composition chimique , Plomb/sang , Plomb/toxicité , Hormones/sang , Altération de l'ADN
5.
J Endocrinol ; 262(1)2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38727510

RÉSUMÉ

The fundamental models underlying hormonal physiological regulation and homeostasis remain poorly understood. We aimed to derive quantitative evidence regarding these models from the study of population data of balance points of different parameters and their respective controlling hormones. We studied the slopes of correlations between concentrations of circulating free thyroxine and thyrotropin, calcium and parathyroid hormone, hemoglobin and erythropoietin, and glucose and insulin in such population data, as well as the slopes of the limbs of various feedback loops estimated empirically and by reverse engineering of the population data. We used computer simulations to model the factors that influence the slopes derived from the population data, and then matched these simulations with the empirically derived slopes. Our simulations showed that changes to the population distribution of feedback loop limbs may alter the slopes of correlations within population data in specific ways. Non-random (interdependent) associations of the limbs of feedback loops may also have this effect, as well as producing discrepancies between the slopes of feedback limb loops determined experimentally and the same slopes determined by derivation from population data. Our corresponding empirical findings were consistent with the presence of such interdependence in the free thyroxine/thyrotropin, hemoglobin/erythropoietin, and glucose/insulin systems. The glucose/insulin data provided evidence consistent with increasing interdependence with age in childhood. Our findings therefore provide strong evidence that the interdependence of the limbs of feedback loops is a general feature of endocrine homeostatic regulation. This interdependence potentially bestows evolutionary homeostatic and regulatory advantages.


Sujet(s)
Glycémie , Rétrocontrôle physiologique , Insuline , Thyréostimuline , Thyroxine , Humains , Thyroxine/sang , Rétrocontrôle physiologique/physiologie , Thyréostimuline/sang , Insuline/sang , Adulte , Mâle , Femelle , Glycémie/métabolisme , Glycémie/analyse , Simulation numérique , Hormone parathyroïdienne/sang , Adulte d'âge moyen , Enfant , Calcium/sang , Calcium/métabolisme , Adolescent , Érythropoïétine/sang , Modèles biologiques , Hémoglobines/métabolisme , Hémoglobines/analyse , Sujet âgé , Hormones/sang , Homéostasie/physiologie , Jeune adulte
6.
J Vet Med Sci ; 86(7): 756-768, 2024 Jul 02.
Article de Anglais | MEDLINE | ID: mdl-38777756

RÉSUMÉ

Effects of different winter paddock management of Thoroughbred weanlings and yearlings in Hokkaido, Japan, which is extremely cold in winter, on physiological function, endocrine function and growth were investigated. They were divided into two groups; those kept outdoors for 22 hr in the paddock (22hr group) and those kept outdoors for 7 hr in daytime with walking exercise for 1 hr using the horse-walker (7hr+W group), and the changes in daily distance travelled, body temperature (BT), heart rate (HR), HR variability (HRV), endocrine function and growth parameters were compared between the two groups from November at the year of birth to January at 1 year of age. The 7hr+W group could travel almost the same distance as the 22hr group by using the horse-walker. The 22hr group had a lower rate of increase in body weight than the 7hr+W group in January. In addition, lower in BT and HR were observed, and HRV analysis showed an increase in high frequency power spectral density, indicating that parasympathetic nervous activity was dominant. And also, changes in circulating cortisol and thyroxine were not observed despite cold environment. On the other hand, the 7hr+W group had higher prolactin and insulin like growth factor than the 22hr group in January, and cortisol and thyroxine were also increased. Physiological and endocrinological findings from the present study indicate that the management of the 7hr+W group is effective in promoting growth and maintaining metabolism during the winter season.


Sujet(s)
Élevage , Système endocrine , Equus caballus , Japon , Equus caballus/croissance et développement , Élevage/méthodes , Saisons , Système endocrine/physiologie , Basse température , Rythme cardiaque , Mâle , Femelle , Animaux , Hormones/sang , Prise de poids/physiologie , Conditionnement physique d'animal
7.
PLoS One ; 19(5): e0299695, 2024.
Article de Anglais | MEDLINE | ID: mdl-38781203

RÉSUMÉ

BACKGROUND: Ramadan Intermittent Fasting (RIF) has the potential to alter hormonal levels in the body. This study investigates the impact of RIF on hormonal levels among healthy individuals during Ramadan. METHODS: A systematic review and meta-analysis of previously published studies were conducted, focusing on healthy non-athlete adults. The intervention examined was Ramadan Intermittent Fasting, and the primary outcomes assessed were changes in endocrine hormonal and biochemical parameters. The pooled effect measure was expressed as odds ratio (OR) and 95% confidence interval (CI) using the random-effects model. RESULTS: A total of 35 original articles were retrieved, with a combined sample size of 1,107 participants eligible for the meta-analysis. No significant relationship was found between pre- and post-Ramadan hormonal levels of T3, T4, TSH, FT3, FT4, Testosterone, LH, FSH, Prolactin, PTH, Calcium, and Phosphorus (P-value<0.05). However, a substantial decrease in morning cortisol levels was observed across the studies (P-value: 0.08, Hedges' g = -2.14, 95% CI: -4.54, 0.27). CONCLUSIONS: Ramadan Intermittent Fasting results in minimal hormonal changes and is a safe practice for healthy individuals. The fasting regimen appears to disrupt the circadian rhythm, leading to a decrease in morning cortisol levels.


Sujet(s)
Jeûne , Islam , Humains , Jeûne/sang , Adulte , Hormones/sang , Testostérone/sang , Mâle , Hydrocortisone/sang
8.
Int J Mol Sci ; 25(10)2024 May 07.
Article de Anglais | MEDLINE | ID: mdl-38791099

RÉSUMÉ

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive loss of motor neurons. Emerging evidence suggests a potential link between metabolic dysregulation and ALS pathogenesis. This study aimed to investigate the relationship between metabolic hormones and disease progression in ALS patients. A cross-sectional study was conducted involving 44 ALS patients recruited from a tertiary care center. Serum levels of insulin, total amylin, C-peptide, active ghrelin, GIP (gastric inhibitory peptide), GLP-1 active (glucagon-like peptide-1), glucagon, PYY (peptide YY), PP (pancreatic polypeptide), leptin, interleukin-6, MCP-1 (monocyte chemoattractant protein-1), and TNFα (tumor necrosis factor alpha) were measured, and correlations with ALSFRS-R, evolution scores, and biomarkers were analyzed using Spearman correlation coefficients. Subgroup analyses based on ALS subtypes, progression pattern of disease, and disease progression rate patterns were performed. Significant correlations were observed between metabolic hormones and ALS evolution scores. Insulin and amylin exhibited strong correlations with disease progression and clinical functional outcomes, with insulin showing particularly robust associations. Other hormones such as C-peptide, leptin, and GLP-1 also showed correlations with ALS progression and functional status. Subgroup analyses revealed differences in hormone levels based on sex and disease evolution patterns, with male patients showing higher amylin and glucagon levels. ALS patients with slower disease progression exhibited elevated levels of amylin and insulin. Our findings suggest a potential role for metabolic hormones in modulating ALS progression and functional outcomes. Further research is needed to elucidate the underlying mechanisms and explore the therapeutic implications of targeting metabolic pathways in ALS management.


Sujet(s)
Sclérose latérale amyotrophique , Marqueurs biologiques , Insuline , Polypeptide amyloïde des ilots , Humains , Sclérose latérale amyotrophique/métabolisme , Sclérose latérale amyotrophique/sang , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Polypeptide amyloïde des ilots/métabolisme , Polypeptide amyloïde des ilots/sang , Études transversales , Marqueurs biologiques/sang , Insuline/métabolisme , Insuline/sang , Évolution de la maladie , Leptine/sang , Leptine/métabolisme , Glucagon-like peptide 1/métabolisme , Glucagon-like peptide 1/sang , Peptide C/sang , Peptide C/métabolisme , Ghréline/métabolisme , Ghréline/sang , Glucagon/sang , Glucagon/métabolisme , Adulte , Hormones/métabolisme , Hormones/sang
10.
Nature ; 625(7996): 760-767, 2024 Jan.
Article de Anglais | MEDLINE | ID: mdl-38092039

RÉSUMÉ

GDF15, a hormone acting on the brainstem, has been implicated in the nausea and vomiting of pregnancy, including its most severe form, hyperemesis gravidarum (HG), but a full mechanistic understanding is lacking1-4. Here we report that fetal production of GDF15 and maternal sensitivity to it both contribute substantially to the risk of HG. We confirmed that higher GDF15 levels in maternal blood are associated with vomiting in pregnancy and HG. Using mass spectrometry to detect a naturally labelled GDF15 variant, we demonstrate that the vast majority of GDF15 in the maternal plasma is derived from the feto-placental unit. By studying carriers of rare and common genetic variants, we found that low levels of GDF15 in the non-pregnant state increase the risk of developing HG. Conversely, women with ß-thalassaemia, a condition in which GDF15 levels are chronically high5, report very low levels of nausea and vomiting of pregnancy. In mice, the acute food intake response to a bolus of GDF15 is influenced bi-directionally by prior levels of circulating GDF15 in a manner suggesting that this system is susceptible to desensitization. Our findings support a putative causal role for fetally derived GDF15 in the nausea and vomiting of human pregnancy, with maternal sensitivity, at least partly determined by prepregnancy exposure to the hormone, being a major influence on its severity. They also suggest mechanism-based approaches to the treatment and prevention of HG.


Sujet(s)
Facteur-15 de croissance et de différenciation , Hyperémèse gravidique , Nausée , Vomissement , Animaux , Femelle , Humains , Souris , Grossesse , bêta-Thalassémie/sang , bêta-Thalassémie/métabolisme , Foetus/métabolisme , Facteur-15 de croissance et de différenciation/sang , Facteur-15 de croissance et de différenciation/métabolisme , Hormones/sang , Hormones/métabolisme , Hyperémèse gravidique/complications , Hyperémèse gravidique/métabolisme , Hyperémèse gravidique/prévention et contrôle , Hyperémèse gravidique/thérapie , Nausée/sang , Nausée/complications , Nausée/métabolisme , Placenta/métabolisme , Vomissement/sang , Vomissement/complications , Vomissement/métabolisme
11.
Int Clin Psychopharmacol ; 37(6): 255-262, 2022 11 01.
Article de Anglais | MEDLINE | ID: mdl-35779068

RÉSUMÉ

The aim of the study was to evaluate the reference range of amisulpride for Chinese patients with schizophrenia and to assess its possible influencing factors based on therapeutic drug monitoring information. The relative adverse reactions of patients induced by amisulpride were also systematically investigated. A total of 425 patients with schizophrenia were assessed, including Positive and Negative Syndrome Scales, Treatment Emergent Symptom Scale, blood routine examination, hepatorenal function, lipids, hormones, as well as myocardial enzymes at baseline, and following treatment with amisulpride for 8 weeks. The steady-state plasma concentration of amisulpride was assayed using two-dimensional liquid chromatography. At the same dose, the amisulpride plasma concentration of patients combined with clozapine was higher than that without clozapine. The therapeutic reference range of amisulpride can be defined as 230.3-527.1 ng/ml for Chinese patients with schizophrenia. The potential side effects appear to be associated with significantly increased levels of LDH, CK, creatine kinase isoenzyme (CK-MB), TC and decreased level of E 2 , relative to the amisulpride plasma concentration. These findings could provide individualized medication and reduce the adverse effects of amisulpride for Chinese patients with schizophrenia.


Sujet(s)
Amisulpride , Neuroleptiques , Clozapine , Schizophrénie , Amisulpride/effets indésirables , Amisulpride/pharmacocinétique , Neuroleptiques/effets indésirables , Neuroleptiques/pharmacocinétique , Clozapine/pharmacocinétique , Creatine kinase/sang , Surveillance des médicaments , Hormones/sang , Humains , Isoenzymes/sang , Lipides/sang , Schizophrénie/traitement médicamenteux
12.
PLoS One ; 17(2): e0263374, 2022.
Article de Anglais | MEDLINE | ID: mdl-35139096

RÉSUMÉ

PURPOSE: This study aimed to determine the effect of reproductive, hormonal, lifestyle and nutritional factors on breast cancer development among Tanzanian black women. METHODOLOGY: We undertook a case-control study age-matched to ±5years in 2018 at Muhimbili National Hospital. The study recruited 105 BC patients and 190 controls giving it 80% power to detect an odds ratio of ≥2 at the alpha error of <5% for exposure with a prevalence of 30% in the control group with 95% confidence. Controls were recruited from in patients being treated for non-cancer related conditions. Information regarding hormonal, reproductive, nutritional and lifestyle risk for breast cancer and demography was collected by interviews using a predefined data set. Conditional multinomial logistic regression used to determine the adjusted odds ratio for variables that had significant p-value in the binomial logistic regression model with 5% allowed error at 95% confidence interval. RESULTS: The study recruited 105 cases and 190 controls. Only old age at menopause had a significant risk, a 2.6 fold increase. Adolescent obesity, family history of breast cancer, cigarette smoking and alcohol intake had increased odds for breast cancer but failed to reach significant levels. The rural residency had 61% reduced odds for developing breast cancer though it failed to reach significant levels. CONCLUSION: Older age at menopause is a significant risk factor for the development of breast cancer among Tanzanian women. This study has shed light on the potential role of modifiable risk factors for breast cancer which need to be studied further for appropriate preventive strategies in similar settings.


Sujet(s)
Tumeurs du sein/épidémiologie , Hormones/sang , Mode de vie , État nutritionnel/physiologie , Reproduction/physiologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Vieillissement/physiologie , /statistiques et données numériques , Tumeurs du sein/ethnologie , Tumeurs du sein/étiologie , Études cas-témoins , Femelle , Hormones/physiologie , Humains , Mode de vie/ethnologie , Ménopause/physiologie , Adulte d'âge moyen , Parité/physiologie , Obésité pédiatrique/complications , Obésité pédiatrique/épidémiologie , Grossesse , Facteurs de risque , Facteurs socioéconomiques , Tanzanie/épidémiologie , Jeune adulte
13.
J Ovarian Res ; 15(1): 14, 2022 Jan 23.
Article de Anglais | MEDLINE | ID: mdl-35067219

RÉSUMÉ

BACKGROUND: Ginseng is a powerful phytoestrogen with high antioxidant properties. OBJECTIVE: This study aimed to evaluate the effect of Panax Ginseng (PG) on folliculogenesis, proliferation, and apoptosis in the ovary impaired by nicotine. METHODS: Forty adult mice were divided into five groups. Control, sham, and nicotine groups, and co-treated groups of nicotine and ginseng in doses of 0.5 and 1 g/kg. Folliculogenesis was assessed via histopathology and serum evaluation of estradiol, progesterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) by ELISA. Lipid peroxidation and antioxidant enzyme activities both in homogenate tissue and serum were assayed by colorimetric analysis. Apoptotic markers of cytochrome c (Cyt c), Bax, and Bcl-2 were evaluated by RT-PCR. Proliferative index was studied by the Ki-67 immunostaining procedure. RESULTS: In comparison to the control or sham groups, nicotine significantly reduced the levels of FSH, LH, and estradiol hormones. An insignificant reduction was observed in the progesterone hormone. Nicotine reduced all healthy follicle numbers, except primordial (P = 0.001). Malondialdehyde (MDA) was increased in tissue and serum in the nicotine group (P = 0.01). Serum catalase (CAT) and enzymatic activity of superoxide dismutase (SOD) both were reduced in tissue and the serum, in the nicotine group. Nicotine induced a reduction in the proliferative indexes of granulosa and theca cells in pre-antral and antral follicles (P = 0.001). However, its effect on the proliferative index of stroma cells was not significant. Apoptotic markers were elevated in the nicotine group (P = 0.001). Co-treatment with ginseng elevated all sex hormones, increased healthy follicles, and reduced tissue or serum lipid peroxidation, compared with the nicotine group (p < 0.05). Co-Treatment with ginseng also reduced the expression of apoptotic markers and increased the proliferative indexes in granulosa and theca cells in pre-antral and antral follicles and also in stroma cells, in comparison to the nicotine group (P = 0.001). All above-mentioned alterations following treatment with ginseng were remarkable, especially in the dose of 1 g/kg. CONCLUSION: This study showed ginseng protects folliculogenesis via alteration of hypothalamic- pituitary-gonadal (HPG) axis, induction of proliferation in ovarian somatic cells, reduction of lipid peroxidation, and downregulation of apoptotic markers in the mouse ovary, treated with nicotine.


Sujet(s)
Nicotine/pharmacologie , Ovaire/effets des médicaments et des substances chimiques , Panax , Préparations à base de plantes/pharmacologie , Animaux , Apoptose/effets des médicaments et des substances chimiques , Protéines régulatrices de l'apoptose/génétique , Catalase/sang , Catalase/métabolisme , Prolifération cellulaire/effets des médicaments et des substances chimiques , Régulation négative/effets des médicaments et des substances chimiques , Femelle , Hormones/sang , Antigène KI-67/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Malonaldéhyde/sang , Souris , Ovaire/croissance et développement , Ovaire/métabolisme , Superoxide dismutase/sang , Superoxide dismutase/métabolisme
14.
BMC Endocr Disord ; 22(1): 30, 2022 Jan 28.
Article de Anglais | MEDLINE | ID: mdl-35090434

RÉSUMÉ

BACKGROUND: Idiopathic hypogonadotropic hypogonadism (IHH) is a type of congenital disease caused by a variety of gene variants leading to dysfunction in the secretion of hypothalamic gonadotropin-releasing hormones (GnRHs). Clinically, IHH can be divided into Kallmann syndrome (KS) with dysosmia and normosmic idiopathic hypogonadotropic hypogonadism (nIHH) according to the presence or absence of an olfactory disorder. METHODS: We retrospectively evaluated 25 IHH patients (8 KS and 17 nIHH) who were diagnosed at the Department of Endocrinology of Shanghai Children's Hospital from 2015 to 2021. We analysed the patients' clinical data, including their hormone levels and gene sequences. RESULTS: All male patients exhibited small phalli, and 35% of them exhibited cryptorchidism. A significant difference was observed in the levels of dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation (P = 0.028) between the KS group and the nIHH group. Missense variants were the major cause of IHH, and the main pathogenic genes were FGFR1, PROKR2/PROK2, and KAl1. Nine reported and 13 novel variants of six genes were identified. De novo variants were detected in 16 IHH patients; eight patients inherited the variants from their mothers, while only three patients inherited variants from their fathers. One patient had both KAl1 and PROKR2 gene variants, and another patient had two different PROKR2 gene variants. These two patients both had the hot spot variant c.533G > C (p. Trp178Ser) of the PROKR2 gene. CONCLUSION: IHH should be highly suspected in patients with a small phallus and cryptorchidism. Compared with nIHH patients, KS patients exhibited a higher level of DHT after HCG stimulation. Missense variants were the major cause of IHH, and most of the inherited variants were from their mothers who exhibited no obvious clinical symptoms. We identified 9 reported variants and 13 novel variants that led to IHH. A small proportion of patients were at risk of inheriting either the oligogenic variant or the compound heterozygous variant. The hot spot variant c.533G > C (p. Trp178Ser) of PROKR2 might be involved in oligogenic inheritance and compound heterozygous inheritance. These findings provide deeper insight into the diagnosis and classification of IHH and will contribute to its clinical assessment.


Sujet(s)
Hypogonadisme/génétique , Adolescent , Marqueurs biologiques/sang , Chine/épidémiologie , Femelle , Hormones/sang , Humains , Hypogonadisme/épidémiologie , Incidence , Mâle , Phénotype , Études rétrospectives
15.
J Strength Cond Res ; 36(9): 2361-2370, 2022 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-33337694

RÉSUMÉ

ABSTRACT: Pihlainen, K, Kyröläinen, H, Santtila, M, Ojanen, T, Raitanen, J, and Häkkinen, K. Effects of combined strength and endurance training on body composition, physical fitness, and serum hormones during a 6-month crisis management operation. J Strength Cond Res 36(9): 2361-2370, 2022-Very few studies have examined the impact of training interventions on soldier readiness during an international military operation. Therefore, the present study investigated the effects of combined strength and endurance training on body composition, physical performance, and hormonal status during a 6-month international military deployment consisting of typical peacekeeping tasks, e.g., patrolling, observation, and on-base duties. Soldiers ( n = 78) were randomly allocated to a control group (C) or one of 3 combined whole-body strength and endurance training groups with varying strength-to-endurance training emphasis (Es = 25/75%, SE = 50/50% or Se = 75/25% of strength/endurance training). Body composition, physical performance (3000-m run, standing long jump [SLJ], isometric maximal voluntary contraction of the lower [MVC lower] and upper extremities [MVC upper ], muscle endurance tests), and selected serum hormone concentrations were determined prior to training (PRE), and after 9 (MID) and 19 (POST) weeks of training. Within- and between-group changes were analyzed using linear regression models. The average combined strength and endurance training frequency of the total subject group was 3 ± 2 training sessions per week. No changes were observed in physical performance variables in the intervention groups, whereas SLJ decreased by 1.9% in C ( p < 0.05). Maximal voluntary contraction lower increased by 12.8% in the combined intervention group ( p < 0.05), and this was significantly different to C ( p < 0.05). Testosterone-to-cortisol ratio increased in SE and Se ( p < 0.05), whereas no change was observed in C. The intervention groups maintained or improved their physical performance during deployment, which is beneficial for operational readiness. However, the high interindividual variation observed in training adaptations highlights the importance of training individualization during prolonged military operations.


Sujet(s)
Composition corporelle , Entrainement d'endurance , Hormones , Aptitude physique , Entraînement en résistance , Composition corporelle/physiologie , Entrainement d'endurance/méthodes , Hormones/sang , Humains , Déploiement militaire , Personnel militaire , Aptitude physique/physiologie , Entraînement en résistance/méthodes
16.
J Cancer Res Clin Oncol ; 148(3): 697-706, 2022 Mar.
Article de Anglais | MEDLINE | ID: mdl-33904982

RÉSUMÉ

PURPOSE: In patients with metastatic functional gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), it is unknown what degree of tumor reduction is required to eliminate hormonal symptoms. We aimed to reduce hormonal symptoms derived from advanced GEP-NENs by efficient minimal intervention, constructing a hormonal tumor map of liver metastases. METHODS: Between 2013 and 2019, we treated 12 insulinoma or gastrinoma patients with liver metastases. Liver segments containing hormone-producing tumors were identified by injecting calcium gluconate via the hepatic arteries and monitoring the change in serum hormone concentration in the three hepatic veins. A greater-than-twofold increase in hormone concentration indicated a tumor-feeding vessel. RESULTS: Cases included eight insulinomas and four gastrinomas. Primary lesions were functional in three patients and nonfunctional in 9. Nine patients showed hormonal step-up indicating the presence of functional lesions; eight showed step-up in tumor-bearing liver segments, while one with synchronous liver metastases showed step-up only in the pancreatic region. Five patients underwent surgery. Serum hormone concentration decreased markedly after removing the culprit lesions in 3; immediate improvement in hormonal symptoms was achieved in all patients. Three patients with previous surgical treatment who showed step-up underwent transcatheter arterial embolization, achieving temporary improvement of hormonal symptoms. Four patients showed unclear localization of the hormone-producing tumors; treatment options were limited, resulting in poor outcomes. CONCLUSION: Hormonal tumor mapping demonstrated heterogeneity in hormone production among primary and metastatic tumors of GEP-NENs. Minimally invasive treatment based on hormonal mapping may be a viable alternative to conventional cytoreduction.


Sujet(s)
Gastrinome/anatomopathologie , Hormones/sang , Insulinome/anatomopathologie , Tumeurs de l'intestin/anatomopathologie , Tumeurs du foie/secondaire , Tumeurs neuroendocrines/anatomopathologie , Tumeurs du pancréas/anatomopathologie , Tumeurs de l'estomac/anatomopathologie , Adulte , Sujet âgé , Femelle , Études de suivi , Gastrinome/sang , Gastrinome/chirurgie , Humains , Insulinome/sang , Insulinome/chirurgie , Tumeurs de l'intestin/sang , Tumeurs de l'intestin/chirurgie , Tumeurs du foie/sang , Tumeurs du foie/chirurgie , Mâle , Adulte d'âge moyen , Tumeurs neuroendocrines/sang , Tumeurs neuroendocrines/chirurgie , Tumeurs du pancréas/sang , Tumeurs du pancréas/chirurgie , Pronostic , Études rétrospectives , Tumeurs de l'estomac/sang , Tumeurs de l'estomac/chirurgie
17.
Article de Anglais | MEDLINE | ID: mdl-34571152

RÉSUMÉ

Female reproductive physiology is greatly dependent on tight regulation of metabolic and survival factors. Photoperiod regulates female reproductive rhythms but very less information exists explaining whether photoperiod could modulate thyroid hormone homeostasis, metabolic/energy parameters along with survival, proliferation and gap junction proteins in the ovary of a long-day breeder, Mesocricetus auratus. Adult female hamsters were exposed to different photoperiodic regimes i.e., critical photoperiod (CP; 12.5L:11.5D), short photoperiod (SP; 8L:16D) and long photoperiod (LP; 16L:8D) for 12 weeks. LP upregulated thyroidal and gonadal activity as apparent by histoarchitecture, thyroid hormone profile [triiodothyronine (T3), thyroxin (T4) and thyroid stimulating hormone (TSH)], luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2) and progesterone (P4) levels when compared with SP exposed hamsters. Further, LP increased thyroid hormone receptor-α/deiodinase-2 (TRα/Dio-2), estrogen receptor-α (ERα)/aromatase and insulin receptor/glucose transporter-4 (IR/GLUT-4) expressions in ovary. Interestingly, ovarian sirtuin-1 (SIRT-1) expression was also upregulated under LP condition along with cell proliferation (proliferating cell nuclear antigen or PCNA), survival (B cell lymphoma-2 or Bcl-2) and gap junction (connexin-43) markers when compared to SP exposed hamsters. We also noted elevated levels of circulatory leptin, insulin along with melatonin and its receptor (MT-1) in ovary under SP condition. Thus, we suggest that photoperiod plays a vital role in regulation of thyroid and reproductive hormone homeostasis along with key metabolic and survival markers in the ovary of adult golden hamsters, M. auratus providing further insight into the regulation of female reproductive seasonality in a long-day breeder.


Sujet(s)
Mesocricetus/métabolisme , Ovaire/métabolisme , Photopériode , Tissu adipeux blanc/anatomie et histologie , Tissu adipeux blanc/métabolisme , Animaux , Prolifération cellulaire , Survie cellulaire , Connexines/métabolisme , Femelle , Hormones/sang , Mesocricetus/anatomie et histologie , Ovaire/anatomie et histologie , Reproduction/physiologie , Saisons , Glande thyroide/anatomie et histologie , Glande thyroide/métabolisme
18.
Eur J Appl Physiol ; 122(1): 199-208, 2022 Jan.
Article de Anglais | MEDLINE | ID: mdl-34643795

RÉSUMÉ

PURPOSE: This study examined and compared select Triad-RED-S components/risk factors in high-level Kenyan male and female distance runners to corresponding control groups; focusing on examining energy intake (EI), bone indices, and hormonal markers. METHODS: A cross-sectional, observational design was used in which Kenyan male and female (n = 30 and n = 26, respectively) middle- and long-distance runners and corresponding male and female control groups (n = 29 and n = 29, respectively) were examined. The participant's bone mineral density (BMD) at the lumbar spine, right femur, and total body were measured using a dual-energy X-ray absorptiometry analysis. Complete blood counts (CBC) were done on the whole blood specimens and hormonal measurements were performed on plasma specimens. In addition, athletes completed metabolic testing to determine maximal oxygen uptakes and 7-day dietary diaries. RESULTS: Overall daily EI across runners and controls within each sex were low, but not significantly different (p > 0.05). Prevalence of low BMD values (Z score < - 2.0) was comparable across groups in each sex (p > 0.05). CBC measures suggested that both runners and controls were healthy. Finally, slight hormonal differences between runners and their respective controls existed (p < 0.05), but were not clinically meaningful or observed in typical Triad-RED-S-related parameters. CONCLUSION: High-level Kenyan male and female runners had low daily EI, but no tendency toward a higher prevalence of low BMD, or Triad-RED-S-related hormonal abnormalities. The occurrence of low EI was not a major risk factor in our athletes; this calls into question whether the current criteria for Triad-RED-S are entirely applicable for athletes of African ethnicity.


Sujet(s)
Athlètes , Métabolisme énergétique/physiologie , Déficience énergétique relative dans le sport/épidémiologie , Absorptiométrie photonique , Hémogramme , Densité osseuse , Études transversales , Ration calorique , Femelle , Hormones/sang , Humains , Kenya/épidémiologie , Mâle , Consommation d'oxygène , Prévalence , Facteurs de risque , Course à pied
19.
Pharmacol Res ; 175: 105979, 2022 01.
Article de Anglais | MEDLINE | ID: mdl-34798266

RÉSUMÉ

The aim of this study was to examine potential postprandial benefits of Pleurotus eryngii in nineteen volunteers with metabolically unhealthy obesity. An acute, randomized, crossover-designed trial comparing a meal with Pleurotus eryngii and a control meal was performed. The two meals matched in macronutrient and caloric content. Participants consumed both meals in random order after an overnight fast. Blood samples were drawn before and 30, 60, 90, 120, 150 and 180 min after meal consumption (in total 266 samples) to determine glucose, insulin, ghrelin, peptide YY, glucagon-like peptide-1 and glicentin. Visual analog scales measuring the subjective perception of hunger and fullness were completed at the same time points. The test meal resulted in lower glucose incremental area under the curve (iAUC). Additionally, the iAUC of the ghrelin response over time was substantially lower after the test meal (p = 0.033). Lower desire to eat and higher fullness was reflected by significantly lower hunger iAUC (p = 0.046) and higher fullness iAUC (p = 0.042) after the test meal. No differences in insulin, PYY, GLP-1 and glicentin were observed. Pleurotus eryngii can ameliorate postprandial glycaemia, appetite and regulate ghrelin levels at the postprandial state. This effect is attributed to the bioactive polysaccharides that inhibit the activity of enzymes catalysing carbohydrate hydrolysis, cause a delayed gastric emptying and glucose absorption.


Sujet(s)
Glycémie , Hormones/sang , Faim , Obésité/sang , Pleurotus , Satiété , Adulte , Sujet âgé , Études croisées , Femelle , Humains , Mâle , Adulte d'âge moyen , Perception , Période post-prandiale
20.
J Diabetes Res ; 2021: 8275303, 2021.
Article de Anglais | MEDLINE | ID: mdl-34950736

RÉSUMÉ

OBJECTIVES: Metformin is the most widely preferred first-line oral antidiabetic agent that results in clear benefits in blood sugar regulation and diabetes-related complications. This study is aimed at assessing the effect of metformin on anthropometric, hormonal, and biochemical parameters in patients with prediabetes or insulin resistance. METHODS: A prepoststudy was conducted among 52 patients with prediabetes or insulin resistance who met the inclusion criteria. Weight, body mass index (BMI), and waist circumference were measured before and 12 months after metformin treatment. Serum concentrations of sex steroids, gonadotropins, and lipids were also assessed. Homeostasis model assessment (HOMA) index and quantitative sensitivity check (QUICKI) index scores were calculated before metformin treatment and after 12 months of use. RESULTS: After 12 months of metformin treatment, female patients had significant reduction in weight, BMI, and waist circumference after adjusting for age. Metformin use for 12 months resulted in significant reduction in mean fasting blood glucose and HbA1c in females only. Total cholesterol decreased significantly among men only and serum HDL-C showed a significant rise among females only. Serum LDL-C and triglycerides did not change significantly in females and males. Our study did now significant changes in ACTH and cortisol levels in both females and males after metformin treatment. Metformin use resulted in significant increase in luteinizing hormone (LH) and progesterone levels in males, while it was associated with significant increase in prolactin, follicular stimulating hormone (FSH), and dehydroepiandrostenedione-sulphate (DHEA-S) levels and significant decrease in total testosterone level in females. CONCLUSION: Metformin treatment in females with prediabetes reduces BMI, waist circumference, fasting blood glucose, and HbA1c. The changes in the studied parameters differed significantly according to sex.


Sujet(s)
Anthropométrie , Glycémie/effets des médicaments et des substances chimiques , Hémoglobine glyquée/métabolisme , Hormones/sang , Hypoglycémiants/usage thérapeutique , Lipides/sang , Metformine/usage thérapeutique , État prédiabétique/traitement médicamenteux , Adulte , Marqueurs biologiques/sang , Glycémie/métabolisme , Femelle , Humains , Hypoglycémiants/effets indésirables , Mâle , Metformine/effets indésirables , Adulte d'âge moyen , État prédiabétique/sang , État prédiabétique/diagnostic , Facteurs temps , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...